Home › Funds › PFM Health Sciences, LP › TMO
PFM Health Sciences, LP position in TMO
THERMO FISHER SCIENTIFIC INC · Industrials
PFM Health Sciences, LP reported holding 28,496 shares of TMO (THERMO FISHER SCIENTIFIC INC) in its Q2 2026 13F filing — a position valued at US$14.3M, representing 1.25% of its reported portfolio and ranking #28 among its reported holdings. PFM Health Sciences, LP has disclosed TMO holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's TMO position evolved
PFM Health Sciences, LP first disclosed a stake in TMO in Q3 2023 at 62,143 shares (US$31.5M). The position peaked in Q3 2024 at 58,433 shares, worth US$36.1M. Across 11 filings, PFM Health Sciences, LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 28,496 shares valued at US$14.3M — an increase of 13,664 shares quarter over quarter.. Notable position changes include a 64% trim in Q4 2024 (shares fell 8% over the following quarter), a 1539% increase in Q4 2025 (shares fell 15% over the following quarter), a 92% increase in Q2 2026 (shares rose 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 62.14K | $31.45M | New |
| Q4 2023 | 51.33K | $27.24M | Reduce |
| Q1 2024 | 58.04K | $33.73M | Add |
| Q2 2024 | 63.65K | $35.20M | Add |
| Q3 2024 | 58.43K | $36.14M | Reduce |
| Q4 2024 | 21.04K | $10.95M | Reduce |
| Q1 2025 | 21.90K | $10.90M | Add |
| Q3 2025 | 2.31K | $1.12M | New |
| Q4 2025 | 37.91K | $21.97M | Add |
| Q1 2026 | 14.83K | $7.29M | Reduce |
| Q2 2026 | 28.50K | $14.29M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TMO and 13F data
TMO (THERMO FISHER SCIENTIFIC INC) is a Industrials company. 29 other funds we track also report a position in TMO — the largest reported positions include Vanguard Group (US$19.78B), Fidelity Management & Research (FMR) (US$7.06B), Franklin Resources (US$3.65B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TMO
- Vanguard Group 34.13M sh · $19.78B · Q4 2025
- Fidelity Management & Research (FMR) 14.08M sh · $7.06B · Q2 2026
- Franklin Resources 7.27M sh · $3.65B · Q2 2026
- MFS Investment Management 2.97M sh · $2.28B · Q2 2026
- BNY Mellon 3.94M sh · $1.97B · Q2 2026
- Dodge & Cox 3.05M sh · $1.53B · Q2 2026
- DODGE & COX 3.05M sh · $1.53B · Q2 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 2.76M sh · $1.38B · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 2.74M sh · $1.37B · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held TMO?
PFM Health Sciences, LP has disclosed TMO holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in TMO?
As of Q2 2026, PFM Health Sciences, LP holds 28.50K shares of TMO (THERMO FISHER SCIENTIFIC INC), valued at $14.29M, representing 1.25% of its reported portfolio and ranking #28.
Has PFM Health Sciences, LP been buying or selling TMO?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in TMO. The position peaked in Q3 2024 at 58.43K shares.
Which other funds hold TMO?
Other major institutional holders of TMO include Vanguard Group, Fidelity Management & Research (FMR), Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.